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Abstract
Spatiotemporal gene expression during cardiac development is a highly regulated process. Activation of key signaling 
pathways involved in electrophysiological programming, such as Notch and Wnt signaling, occurs in early cardiovascular 
development and these pathways are reactivated during pathologic remodeling. Direct targets of these signaling pathways 
have also been associated with inherited arrhythmias such as Brugada syndrome and arrhythmogenic cardiomyopathy. In 
addition, evidence is emerging from animal models that reactivation of Notch and Wnt signaling during cardiac pathology 
may predispose to acquired arrhythmias, underscoring the importance of elucidating the transcriptional and epigenetic 
effects on cardiac gene regulation. Here, we highlight specific examples where gene expression dictates electrophysiological 
properties in both normal and diseased hearts.
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Introduction
The human heart starts beating spontaneously about 3 weeks 
after fertilization [1]. To reach this remarkable milestone, 
embryonic cells must differentiate into various cardiac cell 
types and maintain their identity through regulated spati-
otemporal gene expression [2–5]. Evidence is emerging that 
differential susceptibility to cardiac arrhythmias may arise 
from these early embryonic programming events, mediated 
in part through chamber and regional-specific enhancer 
activity and chromatin patterning [6]. Key mechanisms of 
transcriptional and epigenetic regulation of cardiovascular 
development and pathological states include post-transla-
tional histone modification, non-coding RNA, and DNA 
methylation. Here, we will highlight how chamber-specific 
transcriptional responses and histone modifications collec-
tively function to activate or repress transcriptional activity 
and ultimately direct gene expression, which contributes 
to chamber specificity in electrical homeostasis, as well as 
electrical “remodeling” in disease.
Theory of Metabolic Memory
Modifications to the nucleosome, the basic unit of chromatin 
consisting of DNA coiled around histones, controls packag-
ing of DNA and regulates access of transcription factors to 
the DNA [7]. There are at least 15 types of functional his-
tone modifications which can occur, and the most commonly 
studied modifications in the heart are histone methylation/
demethylation and acetylation/deacetylation [4]. Various 
activating and repressing histone modifications dictate 
gene transcription, and chromatin dysregulation can result 
in pathological cardiac gene expression.
Epigenetic mechanisms have been hypothesized to be a 
crucial interface between genetic and environmental fac-
tors to explain the theory of metabolic memory in diseases 
such as diabetes. Metabolic memory in diabetes focuses on 
the interrelationship between stressors (i.e., hyperglycemia, 
oxidative stress, chronic inflammation), which induce mecha-
nisms that persist after the stressor is removed (i.e., controlled 
hyperglycemia) [8]. In a study by Brasacchio et al., even just 
transient exposure to hyperglycemia resulted in sustained acti-
vation of NF-κB (nuclear factor-kappa B), a key regulator of 
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inflammatory gene expression, which may contribute to the 
later development of diabetic complications [9]. Similarly, it 
is well known that many cardiac injuries can predispose to 
future cardiac arrhythmias, and much work to date has focused 
on understanding this arrhythmogenic substrate at the tissue 
level, including tools to assess fibrosis, though the underlying 
cellular mechanisms are less well understood [10]. Clinically, 
it is well known that arrhythmias such as atrial fibrillation 
beget further atrial fibrillation, and perhaps a similar mecha-
nism for electrical “remodeling” and arrhythmia predisposition 
may also be a crucial interface between genetic predisposition 
and acquired factors including age, hypertension, and diabetes. 
When these electrical changes are long-lasting after removal 
of the stressor, this “remodeling” may be best understood as 
cardiac “reprogramming.”
Our group has shown in a clinically relevant murine heart 
failure model, encompassed by progressive heart failure via 
transverse aortic constriction (TAC) plus small apical myocar-
dial infarction, that Notch signaling is transiently reactivated in 
the adult heart, including reactivation in atrial and ventricular 
cardiomyocytes [11, 12]. Though activation of Notch within 
embryonic cardiomyocytes would lead to cardiomyocyte cell 
division, the effects in the adult heart are quite distinct. Instead 
of kick-starting a regenerative process, Notch activation in 
adult murine myocytes results in sustained alteration to ion 
channel gene expression and electrical currents which predis-
poses to arrhythmias [12]. It will be interesting to understand 
how this signaling process relates to ventricular arrhythmias 
which are frequently associated with heart failure. Indeed, 
Weinheimer et al. built on the clinically relevant heart failure 
mouse model described above and followed this with “deband-
ing” to remove the stressor, thus restoring left-ventricular (LV) 
structure. However, LV function was only partially recovered 
and there was incomplete reversal of transcriptional changes 
associated with heart failure, which correlates with what is 
often seen clinically in heart failure patients [13]. Specifi-
cally, we see that after an initial heart failure diagnosis and 
following guideline directed medical therapy, some patients 
can partially recover cardiac function with resolution of heart 
failure symptoms. However, these patients often regress and 
are re-hospitalized, indicative of persistent mechanisms that 
trigger heart failure. Current work is focused on understanding 
the role of Notch signaling in this process, which we hope may 
ultimately result in better ways to predict which patients are 
most at-risk for life-threatening arrhythmias.
Cardiac Chamber‑Specific Histone 
Modifications and Electrophysiology
Embryologically, the left and right ventricles arise from the 
first and second heart fields, respectively, and are exposed 
to distinct signaling pathways during cardiac development 
[8]. This programming in the form of epigenetic “memory” 
may ultimately underlie some of the baseline electrical 
differences seen within various regions of the adult heart. 
A review by Molina et al. illustrates electrophysiological 
features and differences between the right ventricle (RV) 
and LV [14]. For example, the RV expresses lower levels 
of cardiac  Na+ channels and higher levels of cardiac  K+ 
channels when compared with the LV, which contributes 
to slower conduction in the RV [15]. Specifically, these dif-
ferences can provide a critical substrate for developing life-
threatening arrhythmias that originate in the right ventricle 
including the ventricular outflow tract in disorders such as 
Brugada syndrome, where inherited mutations of the gene 
that encodes  Na+ channels (SCN5A) or the direct Notch sign-
aling pathway target HEY2 (Hairy/enhancer-of-split related 
with YRPW motif protein 2), among other mutations, can 
result in ventricular arrhythmias and sudden cardiac death 
[16, 17].
In addition to regulating baseline physiology, devel-
opmental programming may also dictate the differential 
response to stress in various regions of the heart, a response 
often referred to as reactivation of the “fetal gene program.” 
An early study to distinguish cardiac-specific epigenetic 
regulation of gene expression in normal murine hearts used 
chromatin immunoprecipitation (ChIP) analysis to compare 
LV versus RV expression levels of atrial natriuretic pep-
tide (ANP) and brain natriuretic peptide (BNP). In normal 
wild-type mice, the group found increased levels of Histone 
3 lysine 4 dimethylation (H3K4me2) and Histone 3 lysine 
9 acetylation (H3K9ac) with concomitantly higher expres-
sion levels of ANP and BNP in the LV compared to RV 
[18]. In a separate study by Hohl et al., the group compared 
human non-failing and failing hearts where they showed 
upregulation of ANP and BNP in failing LV compared to 
non-failing LV without changes in H3K9ac or H3K4me2. 
However, there were reductions in the gene-silencing marks 
(H3K9me2 and H3K9me3), illustrating distinct mechanisms 
for gene regulation in the pathological state [19]. To this 
end, it would be interesting to study histone modifications in 
arrhythmogenic right ventricular cardiomyopathy where RV 
dysfunction predominates, given that there is greater upregu-
lation of BNP in the RV compared with the LV in these 
patients [20]. These studies reveal maladaptive reactivation 
of fetal gene programs can occur in a chamber-specific man-
ner and highlight that there may be distinct mechanisms for 
gene regulation via histone modification during homeostasis 
and after cardiac stressors [21].
The Notch signaling pathway regulates multiple aspects of 
embryogenesis, from processes as diverse as cardiac structure 
to programming cardiac electrophysiologic properties [22]. 
We have previously shown that developmental Notch gain of 
function (GOF) mice have increased action potential duration 
(APD) in the LV [11]. Interestingly, in Notch-activated mice, 
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Hey2 expression levels are upregulated in the LV, whereas 
Hey2 expression levels are downregulated in the RV. These 
gene expression changes are associated with increased Histone 
H3 lysine 4 trimethylation (H3K4me3) at the Hey2 promoter 
in the LV, while there is loss of the H3K4me3 marks in the RV. 
Furthermore, the key transcriptional cofactor RBP-J (recom-
bination signal binding protein for immunoglobulin kappa J 
region), is dynamically bound to the proximal Hey2 promoter 
and also to an enhancer specifically within the LV but not in 
the RV [11]. Figure 1a shows a schematic of the “priming” of 
the LV that occurs during early cardiac development, which 
may later facilitate the expression of Hey2 in adulthood fol-
lowing a specific trigger that induces Notch. Collectively, these 
results demonstrate that chamber-specific histone modifica-
tions can result in distinct electrical phenotypes and regulation 
of gene expression.
More recently, we demonstrate how embryonic program-
ming via the Wnt signaling pathway also regulates electro-
physiology in a chamber-specific manner [23, 24]. It has long 
been postulated that Hey2 is regulated by mechanisms in addi-
tion to Notch signaling within the ventricles. We demonstrate 
for the first time that Hey2 is a direct Wnt target only in the 
RV and not the LV, which may have relevance to our under-
standing of RV-specific arrhythmias [23]. Using both Wnt 
gain and loss-of-function approaches, additional genes regu-
lating cardiac electrophysiology, Gja1 (gap junction alpha-1, 
encodes connexin 43) and Scn5a (encodes  Nav1.5 protein), 
were shown to be differentially regulated. Gene expression 
changes result in slower conduction velocity in both the Wnt 
gain and loss-of-function RV, but not LV, though the mecha-
nism of slowed conduction is distinct in these models. Indeed, 
the chamber-specific gene expression changes predispose the 
mice to ventricular tachycardia with physiologic stimulation 
of the RV only. ChIP analysis of wild-type embryonic hearts 
demonstrates enrichment of the active H3K27ac mark in a 
Hey2 enhancer region shown to be bound by the Wnt effector 
β-catenin in the RV only, while a distinct Hey2 enhancer dem-
onstrates H3K27ac enrichment in the embryonic LV. Since 
Hey2 regulates important electrical properties within the RV, 
this example highlights how a chamber-specific understand-
ing of embryonic transcriptional and epigenetic programming 
may help us to better understand arrhythmias which occur later 
in life. Figure 1b represents a model of the “priming” of the 
RV that occurs in early cardiac development, which may later 
facilitate the expression of HEY2 in adulthood following a spe-
cific trigger where Wnt signaling is reactivated.
Histone Modification in Cardiomyopathy
Two hallmark electrophysiological findings in failing hearts 
include conduction slowing and action potential prolonga-
tion. Electrophysiological heterogeneity within the heart 
presupposes the dysregulation of multiple key components 
of the action potential, including downregulation of repolar-
izing  K+ currents (IK1, Ito, IKr, IKs), alterations to depolariz-
ing  Ca2+ currents (ICa-L) and  Ca2+ transporters (NCX, SER-
CA2a), and downregulation of depolarizing  Na+ currents 
(INa). Connexin 43 is a key cardiac gap junction protein that 
can be downregulated or improperly distributed which also 
results in slowed conduction [25, 26].
Several studies have focused on the downregulation of 
repolarizing  K+ currents, offering an illustrative example 
of the interplay between heart failure, electrophysiologic 
remodeling, and histone modifications. In the heart, KCNIP2 
(potassium channel interacting protein 2, which encodes the 
KChIP2 protein) interacts with the subfamily of voltage-
gated potassium channel (Kv4) to increase current density, 
accelerate recovery from inactivation, and slow inactivation 
kinetics [27]. Collectively, changes in KChIP2 levels alters 
the fast component of the cardiac transient outward potas-
sium current (Ito) and contributes to APD prolongation and 
conduction slowing in both humans as well as canine models 
of heart failure [28, 29]. As discussed above, cardiac injuries 
and subsequent progression to heart failure reactivates Notch 
signaling in mouse models of heart failure, with concomitant 
downregulation of Kcnip2, and loss of H3K4me3 associated 
with dynamic RBP-J binding to the Kcnip2 promoter [11]. 
Bolstering the significance of these findings, a study by Stein 
et al. demonstrated that loss of the same H3K4me3 methyla-
tion site through adult-inducible deletion of PAX-interacting 
protein 1 (PTIP), an essential cofactor for H3K4 methyla-
tion, resulted in reduced Kcnip2 expression levels [30]. In 
addition, PTIP-deficient mice exhibited APD prolongation 
with reduced Ito and development of premature ventricular 
beats. Therefore, understanding how post-translational his-
tone modifications are regulated is relevant to understanding 
cardiac electrophysiology, especially in the setting of heart 
failure.
Downregulation of KCNIP2 has been shown to be a con-
sistent finding across the spectrum of human cardiomyo-
pathies. Exciting work recently demonstrates that KChIP2 
protein not only contributes to Ito, but it also regulates a 
transcriptional network in the heart. In a paper by Nassal 
et al., KChIP2 was shown to regulate microRNAs (miRNA) 
important for conduction and maintenance of electrical sta-
bility through KChIP2 binding to the miR-34b/c promoter 
region in the nucleus, supporting the notion that KChIP2 can 
behave as a transcriptional repressor [31]. In both neonatal 
rat cardiomyocytes exposed to phenylephrine as a mimic 
of neuro-hormonal overload and samples of human heart 
failure tissue, downregulation of KChIP2 and concomitant 
upregulation of miR-34b/c was observed. Restoration of 
KChIP2 expression levels not only reverted miR-34b/c lev-
els back to baseline, but also restored channel function and 
impeded reentrant ventricular arrhythmias in a cell culture 
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model. Given the importance of KCNIP2 in regulating tran-
scription and electrical remodeling in heart failure, under-
standing how it is regulated will be of clinical importance.
More broadly, several exciting studies offer a blueprint 
for understanding the role of epigenetics in heart failure. 
Studies by Rosa-Garrido et al. used genome-wide chroma-
tin conformation capture (Hi–C) of isolated adult cardio-
myocytes from a TAC heart failure mouse model to reveal 
alterations in chromatin compartmentalization and looping, 
demonstrating chromatin remodeling in conjunction with 
decreased enhancer interactions in heart failure [32]. To sup-
port these findings, the team generated a knock-out mouse 
of CTCF, a chromatin structural protein with key roles in 
regulating genome architecture and accessibility [33]. CTCF 
knock-out mice not only mirrored the chromatin remodeling 
findings of the TAC heart failure mice but also recapitulated 
the cardiac dysfunction seen in heart failure. As a clinical 
correlation, CTCF itself was found to be downregulated in 
end-stage heart failure patients requiring left-ventricular 
assist devices. Not surprisingly, CTCF knock-out mice did 
not reveal changes in H3K27me3 nor in H3K4me3, indicat-
ing the effects occurred via an alternative epigenetic mecha-
nism to histone modifications and illustrating the critical 
role CTCF plays in chromatin regulation and heart failure.
Conclusion
Signaling pathways active during cardiac development pro-
gram cardiomyocyte identity. In the adult, these develop-
mental pathways can be reactivated in disease states during 
pathologic remodeling where they can bind to chamber-spe-
cific enhancer and promoter regions and are associated with 
specific histone modifications. These mechanisms of gene 
regulation coordinate differential transcription of genes such 
as HEY2 and KCNIP2 in a chamber-specific manner, which 
may contribute to deadly ventricular arrhythmias.
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